U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07523165) titled 'Efficacy and Safety of Lifei Qingchang Granules for Stable Bronchiectasis' on April 04.
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of Lifei Qingchang Granules in the treatment of patients with stable bronchiectasis. This is a multicenter, randomized, double-blind, placebo-controlled clinical trial.
Researchers plan to enroll a total of 150 adult participants (aged 18-75) who have been diagnosed with stable bronchiectasis and experience at least one acute exacerbation in the past 12 months. Participants will be randomly assigned into two groups in a 1:1 ratio:
* The treatment group will receive...